Drug-induced neurologic disorders in childhood.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000661:Amphetamine / Q000009:adverse effects; D000769:Anesthesia, Inhalation / Q000009:adverse effects; D000772:Anesthesia, Local / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D004035:Diet Therapy / Q000009:adverse effects; D004285:Dogs; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced; D006582:Hexachlorophene / Q000009:adverse effects; D006801:Humans; D007114:Immunization / Q000009:adverse effects; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced; D007263:Infusions, Parenteral / Q000009:adverse effects; D007267:Injections / Q000009:adverse effects; D008297:Male; D008431:Maternal-Fetal Exchange; D008875:Middle Aged; D014663:Nasal Decongestants / Q000009:adverse effects; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000209:etiology; D010597:Pharmacogenetics; D010879:Piperazines / Q000009:adverse effects; D011247:Pregnancy; D014149:Tranquilizing Agents / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D014663:Nasal Decongestants; D010879:Piperazines; D014149:Tranquilizing Agents; D000661:Amphetamine; D006582:Hexachlorophene